CCL2 and colorectal carcinoma: Although combined treatment increased the percentage of infiltrating T-cells, it could be the consequence of increased TAMs, which can recruit regulatory T cells (Tregs) by secreting the chemokine CCL2 resulting in enhancing the immunosuppressive CRC microenvironment [35].